TherapeuticsMD (TXMD) Enterprise Value (2016 - 2025)
Historic Enterprise Value for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to -$7.1 million.
- TherapeuticsMD's Enterprise Value fell 4097.48% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 million, marking a year-over-year decrease of 4097.48%. This contributed to the annual value of -$5.1 million for FY2024, which is 1691.7% down from last year.
- As of Q3 2025, TherapeuticsMD's Enterprise Value stood at -$7.1 million, which was down 4097.48% from -$6.1 million recorded in Q2 2025.
- In the past 5 years, TherapeuticsMD's Enterprise Value registered a high of -$4.3 million during Q4 2023, and its lowest value of -$137.6 million during Q1 2021.
- In the last 5 years, TherapeuticsMD's Enterprise Value had a median value of -$13.7 million in 2023 and averaged -$36.4 million.
- Per our database at Business Quant, TherapeuticsMD's Enterprise Value surged by 9285.58% in 2023 and then tumbled by 4097.48% in 2025.
- Quarter analysis of 5 years shows TherapeuticsMD's Enterprise Value stood at -$64.9 million in 2021, then grew by 6.69% to -$60.6 million in 2022, then soared by 92.86% to -$4.3 million in 2023, then dropped by 16.92% to -$5.1 million in 2024, then tumbled by 40.64% to -$7.1 million in 2025.
- Its last three reported values are -$7.1 million in Q3 2025, -$6.1 million for Q2 2025, and -$5.7 million during Q1 2025.